creatine has been researched along with Child Mental Disorders in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Even though the diagnostic yield of urine creatine metabolite panel is low, it can successfully detect CCDD patients, despite many neurodevelopmental disorders are not a result of CCDD." | 7.96 | Urine creatine metabolite panel as a screening test in neurodevelopmental disorders. ( Bahl, S; Cordeiro, D; MacNeil, L; Mercimek-Andrews, S; Schulze, A, 2020) |
| " We illustrate these limitations of norm-referenced scores, and relative advantages of ability scores, using data from studies of autism spectrum disorder and creatine transporter deficiency." | 3.96 | Person Ability Scores as an Alternative to Norm-Referenced Scores as Outcome Measures in Studies of Neurodevelopmental Disorders. ( Akshoomoff, N; Anselm, I; Barshop, BA; Bennett, A; Berry, L; Berry-Kravis, E; Bianconi, S; Bruchey, A; Cecil, KM; Davis, RJ; Farmer, CA; Ficicioglu, C; Goin-Kochel, RP; Guthrie, W; Kaat, AJ; Koeberl, D; Leonczyk, C; Love-Nichols, J; Mamak, E; Mercimek-Andrews, S; Miller, JS; Porter, FD; Spiridigliozzi, GA; Sullivan, N; Sutton, VR; Thomas, RP; Thurm, A; Udhnani, MD; Wainer, A; Waisbren, SE, 2020) |
| "Even though the diagnostic yield of urine creatine metabolite panel is low, it can successfully detect CCDD patients, despite many neurodevelopmental disorders are not a result of CCDD." | 3.96 | Urine creatine metabolite panel as a screening test in neurodevelopmental disorders. ( Bahl, S; Cordeiro, D; MacNeil, L; Mercimek-Andrews, S; Schulze, A, 2020) |
| "In healthy term newborns with chorioamnionitis, MRS ratios shortly after birth may provide evidence of occult neuroinflammation, which may be associated with worse performance on 1-year neurodevelopmental tests." | 1.42 | Proton magnetic resonance spectroscopy and outcome in term neonates with chorioamnionitis. ( Bentzley, JP; Brown, T; Hope, K; Jenkins, DD; Johnson, CB; Katikaneni, LD; Lambert, D; Morgan, PS; Mulvihill, DM; Ramakrishnan, V; Rollins, LG, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Passi, GR | 1 |
| Pandey, S | 1 |
| Devi, ARR | 1 |
| Konanki, R | 1 |
| Jain, AR | 1 |
| Bhatnagar, S | 1 |
| Tripathi, R | 1 |
| Jain, V | 1 |
| Farmer, CA | 1 |
| Kaat, AJ | 1 |
| Thurm, A | 1 |
| Anselm, I | 1 |
| Akshoomoff, N | 1 |
| Bennett, A | 1 |
| Berry, L | 1 |
| Bruchey, A | 1 |
| Barshop, BA | 1 |
| Berry-Kravis, E | 1 |
| Bianconi, S | 1 |
| Cecil, KM | 1 |
| Davis, RJ | 1 |
| Ficicioglu, C | 1 |
| Porter, FD | 1 |
| Wainer, A | 1 |
| Goin-Kochel, RP | 1 |
| Leonczyk, C | 1 |
| Guthrie, W | 1 |
| Koeberl, D | 1 |
| Love-Nichols, J | 1 |
| Mamak, E | 1 |
| Mercimek-Andrews, S | 2 |
| Thomas, RP | 1 |
| Spiridigliozzi, GA | 1 |
| Sullivan, N | 1 |
| Sutton, VR | 1 |
| Udhnani, MD | 1 |
| Waisbren, SE | 1 |
| Miller, JS | 1 |
| Bahl, S | 1 |
| Cordeiro, D | 1 |
| MacNeil, L | 1 |
| Schulze, A | 1 |
| Hyodo, R | 1 |
| Sato, Y | 1 |
| Ito, M | 1 |
| Sugiyama, Y | 1 |
| Ogawa, C | 1 |
| Kawai, H | 1 |
| Nakane, T | 1 |
| Saito, A | 1 |
| Hirakawa, A | 1 |
| Kidokoro, H | 1 |
| Natsume, J | 1 |
| Hayakawa, M | 1 |
| Barta, H | 1 |
| Jermendy, A | 1 |
| Kolossvary, M | 1 |
| Kozak, LR | 1 |
| Lakatos, A | 1 |
| Meder, U | 1 |
| Szabo, M | 1 |
| Rudas, G | 1 |
| Johnson, CB | 1 |
| Jenkins, DD | 1 |
| Bentzley, JP | 1 |
| Lambert, D | 1 |
| Hope, K | 1 |
| Rollins, LG | 1 |
| Morgan, PS | 1 |
| Brown, T | 1 |
| Ramakrishnan, V | 1 |
| Mulvihill, DM | 1 |
| Katikaneni, LD | 1 |
6 other studies available for creatine and Child Mental Disorders
| Article | Year |
|---|---|
Cerebral creatine deficiency disorders - A clinical, genetic and follow up study from India.
Topics: Brain Diseases, Metabolic, Inborn; Child; Child, Preschool; Creatine; Female; Follow-Up Studies; Gua | 2022 |
Person Ability Scores as an Alternative to Norm-Referenced Scores as Outcome Measures in Studies of Neurodevelopmental Disorders.
Topics: Autism Spectrum Disorder; Brain Diseases, Metabolic, Inborn; Child; Creatine; Humans; Mental Retarda | 2020 |
Urine creatine metabolite panel as a screening test in neurodevelopmental disorders.
Topics: Brain Diseases, Metabolic, Inborn; Canada; Creatine; Female; Guanidinoacetate N-Methyltransferase; H | 2020 |
Magnetic resonance spectroscopy in preterm infants: association with neurodevelopmental outcomes.
Topics: Aspartic Acid; Brain; Child Development; Choline; Creatine; Female; Humans; Infant; Infant, Newborn; | 2018 |
Prognostic value of early, conventional proton magnetic resonance spectroscopy in cooled asphyxiated infants.
Topics: Aspartic Acid; Brain; Creatine; Epilepsy; Female; Hearing Loss; Hospital Mortality; Humans; Hypother | 2018 |
Proton magnetic resonance spectroscopy and outcome in term neonates with chorioamnionitis.
Topics: Basal Ganglia; Brain; Choline; Chorioamnionitis; Creatine; Dipeptides; Female; Healthy Volunteers; H | 2015 |